SE8304737L - Karbostyrilderivat - Google Patents

Karbostyrilderivat

Info

Publication number
SE8304737L
SE8304737L SE8304737A SE8304737A SE8304737L SE 8304737 L SE8304737 L SE 8304737L SE 8304737 A SE8304737 A SE 8304737A SE 8304737 A SE8304737 A SE 8304737A SE 8304737 L SE8304737 L SE 8304737L
Authority
SE
Sweden
Prior art keywords
agents
carbostyril derivatives
carbostyril
useful
hypotensive
Prior art date
Application number
SE8304737A
Other languages
English (en)
Other versions
SE455503B (sv
SE8304737D0 (sv
Inventor
T Tanaka
K Nagami
S Tamada
K Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15409082A external-priority patent/JPS5962585A/ja
Priority claimed from JP57213167A external-priority patent/JPS59104378A/ja
Priority claimed from JP58114679A external-priority patent/JPS606685A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8304737D0 publication Critical patent/SE8304737D0/sv
Publication of SE8304737L publication Critical patent/SE8304737L/sv
Publication of SE455503B publication Critical patent/SE455503B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE8304737A 1982-09-03 1983-09-02 Karbostyrilderivat och framstellning och farmaceutisk kompostion derav SE455503B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15409082A JPS5962585A (ja) 1982-09-03 1982-09-03 カルボスチリル誘導体
JP57213167A JPS59104378A (ja) 1982-12-03 1982-12-03 カルボスチリル誘導体
JP58114679A JPS606685A (ja) 1983-06-24 1983-06-24 カルボスチリル誘導体

Publications (3)

Publication Number Publication Date
SE8304737D0 SE8304737D0 (sv) 1983-09-02
SE8304737L true SE8304737L (sv) 1984-03-04
SE455503B SE455503B (sv) 1988-07-18

Family

ID=27312797

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304737A SE455503B (sv) 1982-09-03 1983-09-02 Karbostyrilderivat och framstellning och farmaceutisk kompostion derav

Country Status (11)

Country Link
US (1) US4564619A (sv)
KR (1) KR910000181B1 (sv)
CA (1) CA1252469A (sv)
CH (1) CH655110A5 (sv)
DE (1) DE3331808A1 (sv)
ES (4) ES525346A0 (sv)
FR (1) FR2532648B1 (sv)
GB (1) GB2127402B (sv)
IT (1) IT1193145B (sv)
NL (1) NL8303066A (sv)
SE (1) SE455503B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
KR100305515B1 (ko) * 1999-02-04 2001-09-24 이순금 메주의 제조방법
NL1012886C1 (nl) * 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan.
KR100422242B1 (ko) * 2001-07-20 2004-03-12 농업회사법인(주)맛가마식품 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
CA2501534A1 (en) * 2002-10-07 2004-04-22 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
NL1028564C2 (nl) * 2005-03-17 2006-09-20 Rademaker Holding B V Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten.
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2007223036A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2026813A2 (en) * 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971797A (en) * 1973-06-15 1976-07-27 Merck & Co., Inc. S,S'-bis(pyridylmethyl)-carbonodithioates
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2659665A1 (de) * 1976-12-30 1978-07-13 Nattermann A & Cie Neue 1,4-dihydropyridin-derivate
JPS5387368A (en) * 1977-01-12 1978-08-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5390270A (en) * 1977-01-14 1978-08-08 Otsuka Pharmaceut Co Ltd Carbostryl derivs.
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
IT1097538B (it) * 1978-07-17 1985-08-31 Medea Res Srl Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts

Also Published As

Publication number Publication date
FR2532648A1 (fr) 1984-03-09
KR850000402A (ko) 1985-02-27
SE455503B (sv) 1988-07-18
ES8502686A1 (es) 1985-01-16
ES8505998A1 (es) 1985-06-16
IT1193145B (it) 1988-06-02
KR910000181B1 (ko) 1991-01-21
CA1252469A (en) 1989-04-11
ES532536A0 (es) 1985-06-16
DE3331808A1 (de) 1984-03-08
IT8367922A0 (it) 1983-09-05
NL8303066A (nl) 1984-04-02
ES532537A0 (es) 1985-10-16
ES8601187A1 (es) 1985-10-16
GB8323542D0 (en) 1983-10-05
ES8506697A1 (es) 1985-07-16
FR2532648B1 (fr) 1989-07-21
ES532538A0 (es) 1985-07-16
ES525346A0 (es) 1985-01-16
GB2127402B (en) 1987-01-14
US4564619A (en) 1986-01-14
SE8304737D0 (sv) 1983-09-02
GB2127402A (en) 1984-04-11
CH655110A5 (de) 1986-03-27

Similar Documents

Publication Publication Date Title
SE8304737L (sv) Karbostyrilderivat
RU94013439A (ru) Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения
IE781478L (en) IMIDAZO £2,1-b| QUINAZOLINES
DE69324151D1 (de) Inhibitoren des arginin-ketoamid-enzyms
SE8001736L (sv) Indolerivat med terapeutisk verkan jemte sett for deras framstellning
NO157175C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.
KR900700435A (ko) 신규아민류 및 그 용도
DK339184D0 (da) Imidazoliumforbindelser, mellemprodukter hertil og fremgangsmaade til deres anvendelse
CA2280727A1 (en) Bicyclic amino acids
DK578485A (da) Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler
SE7705370L (sv) 12-azaprostanoinsyror
DK478585A (da) 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
BR9810394A (pt) Azapeptìdeos cìclicos
ES8705382A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
SE8301038L (sv) Tiopyranopyrimidinforeningar och syraadditionssalter derav
NO872812L (no) 4-nitrogensubstituerte isokinolinolforbindelser med terapeutisk aktivitet og fremgangsmŸte for deres fremstilling.
DK478485D0 (da) 4-oxo-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
DE3889532T2 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
IT8421753A0 (it) Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar
TH4948EX (th) อนุพันธ์ต่าง ๆ ของ 3-(ไฮดรอกซิเมธิล) -ไอโซควิโนลีน, กรรมวิธีสำหรับการเตรียมสารเหล่านั้น และสารผสมทางเภสัชกรรมที่มีสารชนิดเดียวกันนี้อยู่ด้วย
DE3887005T2 (de) Mittel zur Behandlung von Nierenbeschwerden.
NO20000860L (no) Syklopeptidderivater som adhesjonsinhibitorer
RU93004718A (ru) Гетероциклические производные, способ их получения, применение, способ лечения, фармацевтическая композиция

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8304737-3

Effective date: 19940410

Format of ref document f/p: F